You know what they say about something that seems too good to be true...
As for the article... I've always read that "cancer" is not one disease, and that's part of why it's so hard to treat, so they're saying "one cure that will fix everything in everybody" is a little hard to take at face value.
Having said that, it sure would be great it turned out to be true!!
AEBi is in the process of writing patents on specific peptides, which will be a large bank of targeting toxin peptides wholly owned and hard to break.
quote:
Next, AEBi will begin a round of clinical trials which could be completed within a few years and would make the treatment available in specific cases.
The article gives the lie to the headline.
It seems a sound approach that could address many different cancers because its not planned to be 'off the shelf' - its planned to be personalized, similiar to Idec's approach, which means some lag between dx and treatment, during which the patient would need to avoid Rx so the tumor's characteristics dont change - could possible use radiation during the wait, maybe. 'Watchful waiting' is hard on cancer patients. It will be an interesting series of clinical trials to run - I'm looking forward to their phase 1 (safety in humans ) data.
quote:
According to Morad, the MuTaTo cancer treatment will eventually be designed specifically for each person. A piece of each patient’s biopsy will be given to the lab, which will then analyze it to know which receptors are over-expressed, he said. “The individual would then be administered exactly the molecule cocktail needed to cure his disease.”
I wonder if they plan to tackle blood or brain cancers?
-------------------------------- OT's ball 'n chain